Literature DB >> 22078548

Phenotypic and molecular characterization of serogroup C Neisseria meningitidis associated with an outbreak in Bahia, Brazil.

Maria Cecília O Gorla1, Ana Paula S de Lemos, Márcia Quaresma, Rita Vilasboas, Orgali Marques, Márcia U de Sá, Cinthya T Ogassavara, Maria Cristina de C Brandileone, Lee H Harrison, Juarez Dias.   

Abstract

OBJECTIVE: To characterize meningococcal strains isolated from five cases of meningococcal disease (MD) associated with an outbreak in Trancoso - BA, occurred in October 2009. All cases, with the exception of a 39-year-old male, attended a dance party with approximately 1000 youngsters in a rural site.
MATERIALS AND METHODS: The epidemiological investigation was conducted by the Epidemiological Surveillance Service of Bahia State. Meningococcal strains were characterized at Adolfo Lutz Institute, the Brazilian National Reference Laboratory for Bacterial Meningitis by conventional techniques (serotype, serosubtype and antimicrobial susceptibility test) and by molecular methods (Pulsed-field gel electrophoresis - PFGE and Multilocus Sequence Typing - MLST).
RESULTS: The PFGE showed 2 closely related restriction profiles, designated as PFGE types A and A1, having 92% relatedness to each other. MLST characterization showed both A and A1 clones were ST-3780, which belongs to the ST-103 complex. All isolates displayed the phenotype C:23:P1.5 and were susceptible to all antibiotics tested.
CONCLUSIONS: This is the first reported MD outbreak associated with serogroup C ST-103 complex in Brazil, as well as the party and illicit drug-use associated outbreak.
Copyright © 2011 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22078548      PMCID: PMC4807656          DOI: 10.1016/j.eimc.2011.07.022

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  25 in total

1.  Serogroup W135 meningococcal disease in Hajj pilgrims.

Authors:  M K Taha; M Achtman; J M Alonso; B Greenwood; M Ramsay; A Fox; S Gray; E Kaczmarski
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

2.  Role of horizontal genetic exchange in the antigenic variation of the class 1 outer membrane protein of Neisseria meningitidis.

Authors:  I M Feavers; A B Heath; J A Bygraves; M C Maiden
Journal:  Mol Microbiol       Date:  1992-02       Impact factor: 3.501

Review 3.  Respiratory complications of cocaine abuse.

Authors:  J A Perper; D H Van Thiel
Journal:  Recent Dev Alcohol       Date:  1992

4.  Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis.

Authors:  P S Moore; J Hierholzer; W DeWitt; K Gouan; D Djoré; T Lippeveld; B Plikaytis; C V Broome
Journal:  JAMA       Date:  1990-09-12       Impact factor: 56.272

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis.

Authors:  C M Whalen; J C Hockin; A Ryan; F Ashton
Journal:  JAMA       Date:  1995-02-01       Impact factor: 56.272

7.  Cluster of serogroup C meningococcal disease associated with attendance at a party.

Authors:  R Finn; C Groves; M Coe; M Pass; L H Harrison
Journal:  South Med J       Date:  2001-12       Impact factor: 0.954

8.  A cluster of meningococcal disease on a school bus following epidemic influenza.

Authors:  L H Harrison; C W Armstrong; S R Jenkins; M W Harmon; G W Ajello; G B Miller; C V Broome
Journal:  Arch Intern Med       Date:  1991-05

9.  Antigenic shift and increased incidence of meningococcal disease.

Authors:  Lee H Harrison; Keith A Jolley; Kathleen A Shutt; Jane W Marsh; Mary O'Leary; Laurie Thomson Sanza; Martin C J Maiden
Journal:  J Infect Dis       Date:  2006-03-28       Impact factor: 5.226

10.  Genomic fingerprinting of Neisseria meningitidis associated with group C meningococcal disease in Canada.

Authors:  C A Strathdee; S D Tyler; J A Ryan; W M Johnson; F E Ashton
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

View more
  12 in total

1.  Carriage rate and effects of vaccination after outbreaks of serogroup C meningococcal disease, Brazil, 2010.

Authors:  Marco Aurelio Palazzi Sáfadi; Telma Regina Marques Pinto Carvalhanas; Ana Paula de Lemos; Maria Cecilia Outeiro Gorla; Maristela Salgado; Lucila O Fukasawa; Maria Gisele Gonçalves; Fabio Higa; Maria Cristina Cunto Brandileone; Claudio Tavares Sacchi; Ana Freitas Ribeiro; Helena Keico Sato; Lucia Ferro Bricks; José Cassio de Moraes
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

2.  Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital.

Authors:  C A C Gioia; A P S Lemos; M C O Gorla; R Mendoza-Sassi; B S Figueredo; T Ballester; A Von Groll; B Wedig; N V Ethur; L Bragança; P E A Silva; L G Milagres
Journal:  Braz J Med Biol Res       Date:  2017-04-20       Impact factor: 2.590

3.  The invasive Neisseria meningitidis MenC CC103 from Brazil is characterized by an accessory gene repertoire.

Authors:  Michel Abanto Marin; Erica Fonseca; Fernando Encinas; Fernanda Freitas; Dhian Almeida Camargo; Roney Santos Coimbra; Ivano de Filippis; Ana Carolina Vicente
Journal:  Sci Rep       Date:  2017-05-09       Impact factor: 4.379

4.  Evaluation of the impact of serogroup C meningococcal disease vaccination program in Brazil and its regions: a population-based study, 2001-2013.

Authors:  Camile de Moraes; José Cássio de Moraes; Gabriela Drummond Marques da Silva; Elisabeth Carmen Duarte
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-04       Impact factor: 2.743

5.  Combined effect of PCV10 and meningococcal C conjugate vaccination on meningitis mortality among children under five years of age in Brazil.

Authors:  Ana Luiza Bierrenbach; Ruth Minamisava; Airlane Pereira Alencar; Gizelton Pereira Alencar; Ana Lucia Andrade
Journal:  Hum Vaccin Immunother       Date:  2017-12-01       Impact factor: 3.452

6.  Molecular characterization of Neisseria meningitidis isolates recovered from 11-19-year-old meningococcal carriers in Salvador, Brazil.

Authors:  Ana Rafaela Silva Simões Moura; Cécilia Batmalle Kretz; Italo Eustáquio Ferreira; Amélia Maria Pithon Borges Nunes; José Cássio de Moraes; Mitermayer Galvão Reis; Alan John Alexander McBride; Xin Wang; Leila Carvalho Campos
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

7.  Molecular characterization of invasive Neisseria meningitidis strains isolated in Chile during 2010-2011.

Authors:  Gisselle N Barra; Pamela A Araya; Jorge O Fernandez; Jean-Marc Gabastou; Juan Carlos Hormazábal; Mabel Seoane; Paola C Pidal; Maria T Valenzuela; Ana Belén Ibarz-Pavón
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

8.  Phenotypic and genotypic characteristics of Neisseria meningitidis disease-causing strains in Argentina, 2010.

Authors:  Cecilia Sorhouet-Pereira; Adriana Efron; Paula Gagetti; Diego Faccone; Mabel Regueira; Alejandra Corso; Jean-Marc Gabastou; Ana Belén Ibarz-Pavón
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

9.  Short-term and long-term antibody response by mice after immunization against Neisseria meningitidis B or diphtheria toxoid.

Authors:  G P Silva; S C Cruz; A C Cruz; L G Milagres
Journal:  Braz J Med Biol Res       Date:  2013-02-01       Impact factor: 2.590

10.  Three outbreak-causing Neisseria meningitidis serogroup C clones, Brazil(1.).

Authors:  David E Barroso; Terezinha M P P Castiñeiras; Fernanda S Freitas; Jane W Marsh; Mary G Krauland; Mary M Tulenko; Érica L Fonseca; Ana C P Vicente; Maria C Rebelo; Elaine O Cerqueira; Adriano C Xavier; Ana P C M Cardozo; Simone E M da Silva; Lee H Harrison
Journal:  Emerg Infect Dis       Date:  2013-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.